Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07422337
Recruiting
A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
Not applicable · United States · 2 sites
Registry update: 28 Oct 2026
NCT07428161
Recruiting
Investigation of the Effects of Task-Oriented Circuit Training on Upper Extremity Motor Function in Stroke Patients
Not applicable · 1 site
Registry update: 25 Feb 2026
NCT07227038
Recruiting
Living Well With Advanced Breast Cancer
Not applicable · United States · 1 site
Registry update: 19 Mar 2026
NCT07190300
Recruiting
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Phase 1/2 · Australia, Brazil, Canada, China, Germany, Spain, France, United Kingdom, Hong Kong, Hungary, Italy, South Korea, United States · 37 sites
Registry update: 29 Sept 2026
NCT07269262
Recruiting
SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
Not applicable · United States · 1 site
Registry update: 11 Sept 2026
NCT07250217
Recruiting
Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients
Not applicable · France · 2 sites
Registry update: 4 Feb 2026
NCT07344311
Recruiting
A Phase I Trial of A-CAR032 in Participants With mCRPC
Phase 1 · China · 4 sites
Registry update: 16 Oct 2026
NCT06919224
Recruiting
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
Not applicable · United States · 4 sites
Registry update: 23 Mar 2026
NCT07229235
Recruiting
REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria
Not applicable · Italy · 10 sites
Registry update: 25 Jun 2026
NCT07216560
Recruiting
First-in-human Study of 7MW4911 in GI Cancer
Phase 1/2 · United States · 6 sites
Registry update: 2 Nov 2026
NCT07218211
Recruiting
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
Phase 4 · United States · 1 site
Registry update: 19 Oct 2026
NCT07207642
Recruiting
Sweet Night (Musical Diffusion by Caregivers ): Effects of Musical Diffusion by Caregivers on Sleep Onset and Behavioral Regulation in a Protected Living
Not applicable · France · 1 site
Registry update: 26 Jan 2026
NCT07164456
Recruiting
Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers
Not applicable · United States · 1 site
Registry update: 9 Mar 2026
NCT07249632
Recruiting
A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)
Phase 3 · China · 1 site
Registry update: 9 Apr 2026
NCT06931717
Recruiting
A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy
Phase 3 · Austria, Switzerland, Germany, Estonia, Spain, France, Ireland, Italy, Singapore · 33 sites
Registry update: 28 Oct 2026
NCT07049055
Recruiting
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
Phase 1/2 · United States · 4 sites
Registry update: 27 Feb 2026
NCT07315750
Recruiting
A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
Phase 3 · China · 1 site
Registry update: 22 Sept 2026
NCT07402642
Recruiting
Effect of Early Educational Intervention on Cardiovascular Risk Factors After Acute Coronary Syndrome
Not applicable · Spain · 1 site
Registry update: 11 Feb 2026
NCT07369882
Recruiting
Comparison of Efficacy Between De-escalated Surgery and Standard Surgery After Neoadjuvant Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
Not applicable · China · 1 site
Registry update: 27 Jan 2026
NCT07102342
Recruiting
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
Phase 1/2 · United States · 1 site
Registry update: 11 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.